BETASERON Safety Questions, BETASERON Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about BETASERON. Our extensive database of BETASERON adverse events and BETASERON warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about BETASERON

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet



BETASERON Safety Reports

Total BETASERON reports: 2428.
BETASERON FDA safety alerts: 2005 .
Reported deaths: 258    Reported hospitalizations: 1324.
Take BETASERON Side Effects Survey or Share Your BETASERON Story. BETASERON Usage.

Showing 1-75 of 2428 Next >

Consumer or non-health professional from SWEDEN reported BETASERON problem on Jan 04, 2007. Female patient, 26 years of age, was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: abdominal pain, diarrhoea haemorrhagic. BETASERON dosage: .5 ML, 1X/WEEK. Patient was hospitalized. Patient recovered.

BETASERON problem was reported by a Health Professional from UNITED KINGDOM on Jan 02, 2007. Female patient, 39 years of age, was diagnosed with multiple sclerosis relapse and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: abscess, scar. BETASERON dosage: unknown. During the same period patient was treated with FLUOXETINE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported BETASERON problem on Dec 29, 2006. Female patient, 55 years of age, was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: hepatomegaly, liver function test abnormal, pulmonary congestion. BETASERON dosage: unknown. Patient recovered.

BETASERON problem was reported by a Physician from UNITED STATES on Dec 29, 2006. Male patient, 64 years of age, weighting 114.6 lb, was diagnosed with relapsing-remitting multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: anaemia macrocytic, asthenia, decreased appetite, fall, hypokalaemia, hyponatraemia, hypotension, mental status changes, multiple sclerosis. BETASERON dosage: unknown. During the same period patient was treated with PRESODINE, HALCION, CARBATROL, TYLENOL, LANOXIN, HYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported BETASERON problem on Jan 03, 2007. Female patient, 46 years of age, was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: cholecystectomy. BETASERON dosage: unknown. Patient recovered.

BETASERON problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 03, 2007. Female patient, 58 years of age, was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: retinopathy. BETASERON dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported BETASERON problem on Jan 03, 2007. Female patient, 40 years of age, was treated with BETASERON. BETASERON dosage: unknown. Patient died on 01/01/2006.

BETASERON problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 04, 2007. Female patient, 42 years of age, weighting 318.0 lb, was diagnosed with secondary progressive multiple sclerosis, pain and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: hernia repair, impaired healing, influenza like illness, injection site pruritus, injection site urticaria, neutralising antibodies, post procedural complication, postoperative adhesion, postoperative wound infection. BETASERON dosage: unknown. During the same period patient was treated with OXYCODONE, DITROPAN, PAXIL, AMBIEN, DIOVAN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported BETASERON problem on Jan 04, 2007. Female patient, 65 years of age, was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: blood potassium abnormal, gallbladder disorder. BETASERON dosage: unknown. Patient was hospitalized. Patient recovered.

BETASERON problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 04, 2007. Female patient, 52 years of age, was diagnosed with secondary progressive multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: abasia, hypoaesthesia. BETASERON dosage: unknown. During the same period patient was treated with ATENOLOL, LOTREL, ACIPHEX, BACLOFEN, DIAZEPAM, DETROL, HYDROCODONE BITARTRATE, OXYCODONE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported BETASERON problem on Jan 04, 2007. Female patient, 32 years of age, was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: abdominal pain, blood potassium decreased, constipation, cystitis, extremity contracture, hypotension, incoherent, injection site bruising, injection site haemorrhage. BETASERON dosage: unknown. Patient was hospitalized. Patient recovered.

BETASERON problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 04, 2007. Male patient, 47 years of age, weighting 166.0 lb, was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: depression, diarrhoea, musculoskeletal stiffness, weight decreased. BETASERON dosage: unknown. Patient recovered.

Physician from UNITED STATES reported BETASERON problem on Jan 04, 2007. Female patient, 61 years of age, was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: myocardial infarction, thrombosis. BETASERON dosage: unknown. Patient died on 09/16/2006.

BETASERON problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 04, 2007. Male patient, 59 years of age, weighting 146.8 lb, was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: heart rate increased, hypothyroidism. BETASERON dosage: unknown. During the same period patient was treated with ASPIRIN, NEXIUM, HYDROCHLOROTHIAZIDE, ALLOPURINOL, POTASSIUM ACETATE, BACLOFEN, ASACOL, VITAMIN CAP. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported BETASERON problem on Jan 08, 2007. Female patient, 53 years of age, weighting 149.9 lb, was diagnosed with relapsing-remitting multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: coronary artery occlusion, diabetes mellitus. BETASERON dosage: unknown. During the same period patient was treated with LIPITOR, METOPROLOL SUCCINATE, PAROXETINE, BENAZEPRIL HYDROCHLORIDE, OMEPRAZOLE, METFORMIN, IMDUR, ACTOS. Patient was hospitalized. Patient recovered.

BETASERON problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 10, 2007. Female patient, 55 years of age, was diagnosed with multiple sclerosis, nicotine dependence and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: colon cancer, dysphagia, fall, gallbladder disorder, intervertebral disc protrusion, multiple sclerosis, nicotine dependence, pain, pelvic fracture. BETASERON dosage: unknown. During the same period patient was treated with NICOTINE. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported BETASERON problem on Jan 11, 2007. Male patient, 59 years of age, weighting 147.0 lb, was diagnosed with relapsing-remitting multiple sclerosis, depression and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: injection site abscess, injection site infection, injection site necrosis, injection site ulcer, skin graft. BETASERON dosage: unknown. During the same period patient was treated with LEXAPRO, VERAPAMIL, HYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient recovered.

BETASERON problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 10, 2007. Female patient, 52 years of age, weighting 138.9 lb, was diagnosed with relapsing-remitting multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: idiopathic thrombocytopenic purpura, increased tendency to bruise, multiple sclerosis. BETASERON dosage: unknown. During the same period patient was treated with IMMUNOGLOBULINS, SOLGAR VM, MAGNESIUM, EPA XTRA FISH OIL, TIZANIDINE. Patient recovered.

Consumer or non-health professional from CANADA reported BETASERON problem on Jan 11, 2007. Male patient, 56 years of age, weighting 165.3 lb, was diagnosed with relapsing-remitting multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: feeling hot, influenza like illness, localised infection. BETASERON dosage: unknown. During the same period patient was treated with COUMADIN. Patient was hospitalized. Patient recovered.

BETASERON problem was reported by a Consumer or non-health professional from CANADA on Jan 05, 2007. Male patient, 47 years of age, was diagnosed with secondary progressive multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: mobility decreased, pyrexia, tooth infection. BETASERON dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from GERMANY reported BETASERON problem on Jan 16, 2007. Female patient, 47 years of age, was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: autoimmune thyroiditis. BETASERON dosage: unknown. Patient recovered.

BETASERON problem was reported by a Consumer or non-health professional from ARGENTINA on Jan 09, 2007. Male patient, 33 years of age, was diagnosed with multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident. BETASERON dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported BETASERON problem on Jan 08, 2007. Male patient, 49 years of age, was diagnosed with multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: balance disorder, tremor. BETASERON dosage: unknown. Patient was hospitalized. Patient recovered.

BETASERON problem was reported by a Physician from UNITED STATES on Jan 05, 2007. Female patient, 39 years of age, weighting 150.0 lb, was diagnosed with relapsing-remitting multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: anaemia, bladder pain, deep vein thrombosis, depression, hypercoagulation, meningitis bacterial, migraine, multiple sclerosis, nausea. BETASERON dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from GERMANY reported BETASERON problem on Jan 11, 2007. Male patient, 61 years of age, was diagnosed with multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: abdominal pain lower, muscle spasms, musculoskeletal stiffness, pyrexia. BETASERON dosage: unknown. During the same period patient was treated with LEBIC. Patient was hospitalized. Patient recovered.

BETASERON problem was reported by a Consumer or non-health professional from BRAZIL on Jan 11, 2007. Female patient, 50 years of age, was diagnosed with multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: chills, colitis, gastritis, injection site nodule, injection site pain, multiple sclerosis relapse, pyrexia. BETASERON dosage: 1 ML, EVERY 2D. During the same period patient was treated with CARBAMAZEPINE. Patient recovered.

Consumer or non-health professional from ARGENTINA reported BETASERON problem on Jan 09, 2007. Male patient, 44 years of age, was diagnosed with multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: myocardial infarction. BETASERON dosage: unknown. Patient was hospitalized. Patient recovered.

BETASERON problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 05, 2007. Female patient, 49 years of age, was diagnosed with relapsing-remitting multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: alopecia, congenital eye disorder, faecal incontinence, folliculitis, irritable bowel syndrome, scab, urinary incontinence. BETASERON dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported BETASERON problem on Jan 05, 2007. Female patient, 61 years of age, was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: headache, judgement impaired, personality change, suicide attempt. BETASERON dosage: unknown. Patient was hospitalized. Patient recovered.

BETASERON problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 05, 2007. Female patient, 40 years of age, was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: blood potassium decreased, chest pain, discomfort, electrocardiogram t wave abnormal, fatigue, headache, heart rate increased, injection site bruising, pain in extremity. BETASERON dosage: unknown. During the same period patient was treated with BLOOD THINNER. Patient recovered.

Consumer or non-health professional from UNITED STATES reported BETASERON problem on Jan 08, 2007. Female patient, 62 years of age, was diagnosed with secondary progressive multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: multiple sclerosis, pneumonia, pneumonia aspiration. BETASERON dosage: unknown. During the same period patient was treated with VITAMIN B CAP. Patient was hospitalized. Patient recovered.

BETASERON problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 05, 2007. Female patient, 53 years of age, was diagnosed with multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: hemiplegia, influenza like illness, injection site discolouration, lipoatrophy. BETASERON dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported BETASERON problem on Jan 10, 2007. Female patient, 46 years of age, was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: injection site erythema, systemic lupus erythematosus. BETASERON dosage: unknown. Patient recovered.

BETASERON problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 08, 2007. Male patient, 64 years of age, was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, multi-organ failure, pain. BETASERON dosage: unknown. During the same period patient was treated with TYSABRI. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported BETASERON problem on Jan 05, 2007. Female patient, 66 years of age, was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: constipation, nausea, vomiting. BETASERON dosage: unknown. Patient was hospitalized. Patient recovered.

BETASERON problem was reported by a Physician from UNITED STATES on Jan 10, 2007. Female patient was diagnosed with multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: ultrasound antenatal screen abnormal. BETASERON dosage: unknown. Patient recovered.

Physician from UNITED STATES reported BETASERON problem on Jan 10, 2007. Female patient was diagnosed with multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: ultrasound antenatal screen abnormal. BETASERON dosage: unknown. Patient recovered.

BETASERON problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 08, 2007. Male patient, 32 years of age, weighting 205.0 lb, was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: lymphadenopathy, lymphoma. BETASERON dosage: unknown. During the same period patient was treated with CHANTIX, TYLENOL, CALCIUM, VITAMIN B CAP, CORTICOSTEROIDS. Patient recovered.

Physician from UNITED STATES reported BETASERON problem on Jan 11, 2007. Female patient, 34 years of age, weighting 132.3 lb, was diagnosed with relapsing-remitting multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: anaemia, chest pain, dyspnoea, haemolytic uraemic syndrome, renal failure chronic, thrombocytopenia. BETASERON dosage: unknown. During the same period patient was treated with CLARITIN, FLONASE, FOSAMAX, VITAMIN B CAP, VITAMIN D, VASOTEC, NEPHROVITE RENAL SUPPLEMENT, RENAGEL. Patient was hospitalized. Patient recovered.

BETASERON problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 09, 2007. Female patient, 55 years of age, was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: brain neoplasm. BETASERON dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported BETASERON problem on Jan 09, 2007. Female patient, 70 years of age, was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: fall. BETASERON dosage: unknown. Patient was hospitalized. Patient recovered.

BETASERON problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 10, 2007. Female patient, 61 years of age, weighting 177.9 lb, was diagnosed with multiple sclerosis, blood pressure and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: polymyalgia rheumatica, synovial cyst, thrombosis. BETASERON dosage: unknown. During the same period patient was treated with DOXEPIN, AVAPRO, LORAZEPAM. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported BETASERON problem on Jan 11, 2007. Female patient, 54 years of age, was diagnosed with relapsing-remitting multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: facial palsy. BETASERON dosage: unknown. Patient recovered.

BETASERON problem was reported by a Consumer or non-health professional from on Jan 12, 2007. Male patient, 23 years of age, was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: major depression. BETASERON dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported BETASERON problem on Jan 22, 2007. Female patient, 34 years of age, was diagnosed with relapsing-remitting multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: placenta praevia, premature baby, threatened labour. BETASERON dosage: unknown. During the same period patient was treated with PREDONINE. Patient was hospitalized. Patient recovered.

BETASERON problem was reported by a Physician from JAPAN on Jan 17, 2007. Female patient, 33 years of age, was diagnosed with relapsing-remitting multiple sclerosis, gastritis, arthralgia and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: sepsis, urinary tract infection. BETASERON dosage: unknown. During the same period patient was treated with MEDROL, ZANTAC, POLLAKISU, DEPAKENE, LOXONIN, SELBEX. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from ISRAEL reported BETASERON problem on Jan 12, 2007. Female patient, 21 years of age, was diagnosed with multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: hepatic function abnormal, jaundice. BETASERON dosage: unknown. During the same period patient was treated with AVONEX. Patient was hospitalized. Patient recovered.

BETASERON problem was reported by a Physician from GERMANY on Jan 22, 2007. Male patient, 47 years of age, was diagnosed with hypertension and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: chills, cutaneous sarcoidosis, erythema nodosum, injection site discolouration, injection site pain. BETASERON dosage: unknown. During the same period patient was treated with IBUPROFEN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported BETASERON problem on Jan 10, 2007. Female patient, 44 years of age, was diagnosed with relapsing-remitting multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: breast discharge, breast mass, goitre. BETASERON dosage: unknown. Patient recovered.

BETASERON problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 10, 2007. Female patient, 63 years of age, was diagnosed with multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: asthenia, cardiac failure congestive, chronic obstructive pulmonary disease, fall, gait disturbance. BETASERON dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported BETASERON problem on Jan 09, 2007. Male patient, 49 years of age, weighting 168.0 lb, was diagnosed with relapsing-remitting multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, back injury, bladder spasm, blood glucose increased, cerebrosclerosis, diabetes mellitus non-insulin-dependent, fall, gamma-glutamyltransferase increased. BETASERON dosage: unknown. During the same period patient was treated with EFFEXOR, TYSABRI, ZANTIC. Patient recovered.

BETASERON problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 08, 2007. Female patient, 55 years of age, was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: uterine cancer. BETASERON dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported BETASERON problem on Jan 09, 2007. Female patient, 49 years of age, was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: chest pain, heart rate irregular. BETASERON dosage: unknown. Patient was hospitalized. Patient recovered.

BETASERON problem was reported by a Health Professional from UNITED STATES on Jan 09, 2007. Male patient, 49 years of age, was diagnosed with multiple sclerosis, fatigue, vitamin supplementation and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: leukaemia. BETASERON dosage: unknown. During the same period patient was treated with AMANTADINE, NOVANTRONE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported BETASERON problem on Jan 09, 2007. Female patient, 62 years of age, weighting 163.0 lb, was diagnosed with hypertension, pain and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: albumin urine present. BETASERON dosage: unknown. During the same period patient was treated with MAVIK, METOPROLOL SUCCINATE, AVANDIA, ZOCOR, HYDROCODONE BITARTRATE. Patient recovered.

BETASERON problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 10, 2007. Female patient, 50 years of age, was diagnosed with relapsing-remitting multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: abdominal pain, asthenia, clostridium difficile colitis, hypoaesthesia, ileostomy, reversal of ileojejunal bypass. BETASERON dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported BETASERON problem on Jan 10, 2007. Male patient, 38 years of age, was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident. BETASERON dosage: unknown. Patient recovered.

BETASERON problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 10, 2007. Male patient, 49 years of age, was diagnosed with primary progressive multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: amnesia, cognitive disorder, coordination abnormal, dysstasia, fall. BETASERON dosage: unknown. During the same period patient was treated with LOVENOX. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported BETASERON problem on Jan 10, 2007. Female patient, 49 years of age, was diagnosed with relapsing-remitting multiple sclerosis, pain, depression, constipation, hypothyroidism and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: aspiration, choking, influenza like illness, loss of consciousness, neck pain, rash, vomiting. BETASERON dosage: unknown. During the same period patient was treated with METHADONE, VALIUM, MIRALAX, BACLOFEN, SYNTHROID, CYMBALTA, VITAMIN B. Patient was hospitalized. Patient recovered.

BETASERON problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 10, 2007. Female patient, 56 years of age, was diagnosed with progressive multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident. BETASERON dosage: unknown. Patient died on 01/01/2003.

Physician from reported BETASERON problem on Jan 12, 2007. Female patient, 21 years of age, was diagnosed with multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: personality disorder, suicide attempt. BETASERON dosage: unknown. Patient was hospitalized. Patient recovered.

BETASERON problem was reported by a Physician from CANADA on Jan 11, 2007. Female patient, 61 years of age, was diagnosed with relapsing-remitting multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: multiple sclerosis relapse, optic neuritis. BETASERON dosage: unknown. Patient recovered.

Physician from UNITED STATES reported BETASERON problem on Jan 09, 2007. Female patient, 49 years of age, was diagnosed with migraine prophylaxis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: acute hepatic failure, blood potassium decreased, decreased appetite, disorientation, dysarthria, fatigue, fluid retention, migraine, nausea. BETASERON dosage: unknown. During the same period patient was treated with TOPAMAX, TYLENOL. Patient was hospitalized. Patient recovered.

BETASERON problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 10, 2007. Female patient, 58 years of age, weighting 134.5 lb, was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: blood disorder, splenomegaly. BETASERON dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported BETASERON problem on Jan 10, 2007. Female patient, 56 years of age, was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: tooth disorder, tooth fracture. BETASERON dosage: unknown. During the same period patient was treated with PERCOCET, MOTRIN. Patient recovered.

BETASERON problem was reported by a Health Professional from SPAIN on Jan 11, 2007. Female patient, 40 years of age, was diagnosed with cellulitis pharyngeal and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: cellulitis pharyngeal. BETASERON dosage: unknown. During the same period patient was treated with DALACIN, DACORTIN, EMEPROTON. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported BETASERON problem on Jan 10, 2007. Male patient, 79 years of age, was diagnosed with multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: pulmonary oedema, terminal state. BETASERON dosage: unknown. Patient was hospitalized. Patient recovered.

BETASERON problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 10, 2007. Female patient, 58 years of age, was diagnosed with multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: ankle fracture, chest discomfort, hepatic enzyme abnormal, nausea, vomiting. BETASERON dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported BETASERON problem on Jan 10, 2007. Female patient, 66 years of age, was diagnosed with secondary progressive multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: livedo reticularis. BETASERON dosage: unknown. Patient recovered.

BETASERON problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 10, 2007. Female patient was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased. BETASERON dosage: unknown. During the same period patient was treated with NOVANTRONE, AVONEX, BACLOFEN, XANAX, NEURONTIN, PERCOCET, PRENATAL VITAMINS, DETROL. Patient died on 01/01/2003.

Consumer or non-health professional from UNITED STATES reported BETASERON problem on Jan 10, 2007. Female patient, 66 years of age, was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: chest pain, gastric haemorrhage, rectal haemorrhage. BETASERON dosage: unknown. Patient was hospitalized. Patient died on 08/27/2006.

BETASERON problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 10, 2007. Female patient, 45 years of age, was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: alopecia, arthralgia, chills, confusional state, diarrhoea, dysphagia, dyspnoea, gait disturbance. BETASERON dosage: unknown. During the same period patient was treated with HORMONES AND RELATED AGENTS, NEURONTIN, EFEXOR. Patient recovered.

Health Professional from FRANCE reported BETASERON problem on Jan 11, 2007. Female patient, 47 years of age, was diagnosed with multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: papillary thyroid cancer. BETASERON dosage: unknown. Patient was hospitalized. Patient recovered.

BETASERON problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 11, 2007. Female patient, 47 years of age, was diagnosed with multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: intracranial aneurysm. BETASERON dosage: unknown. Patient recovered.

Physician from FINLAND reported BETASERON problem on Jan 11, 2007. Female patient, 24 years of age, was diagnosed with multiple sclerosis, oral contraception, pharyngolaryngeal pain, pyrexia, insomnia and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: knee operation, pyoderma gangrenosum. BETASERON dosage: unknown. During the same period patient was treated with MICROLUTON, PENICILLIN V, ULTRACAIN D, IBUPROFEN, TEMAZEPAM, OMEPRAZOLE, PANACOD. Patient was hospitalized. Patient recovered.

Showing 1-75 of 2428 Next >

Ask Our Patient Community about BETASERON

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z
This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert (aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol
Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol
Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

 F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
HaloperidolThis drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant
Insulin Glulisine recombinant
Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
LinezolidThis drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
MinirinThis drug has as active FDA Safety Alert (desmopressin)
MirtazapineThis drug has as active FDA Safety Alert
MisoprostolThis drug has as active FDA Safety Alert
Mobic (meloxicam)
Modafinil
MoexiprilThis drug has as active FDA Safety Alert
MonoprilThis drug has as active FDA Safety Alert (fosinopril)
Moxifloxacin
MultiHanceThis drug has as active FDA Safety Alert (gadobenate dimeglumine)
Mycamine (micafungin)
Mylotarg (gemtuzumab ozogamicin)

back to top

N
Namenda (memantine)
NaprosynThis drug has as active FDA Safety Alert (naproxen)
NaproxenThis drug has as active FDA Safety Alert
Naratriptan
Nesiritide recombinant
Nateglinide
Natrecor (nesiritide recombinant)
NefazodoneThis drug has as active FDA Safety Alert
Nelarabine
NeoTect Kit (technetium Tc 99m depreotide)
Nesiritide recombinant
NeurontinThis drug has as active FDA Safety Alert (gabapentin)
Nexavar (sorafenib)
Nitazoxanide
Nitisinone
Norelgestromin
NovoLog (insulin aspart recombinant)
Noxafil (posaconazole)

back to top

O
Olanzapine
Olanzapine/fluoxetineThis drug has as active FDA Safety Alert
Olmesartan medoxomil
Omacor (omega-3-acid ethyl esters)
OmalizumabThis drug has as active FDA Safety Alert
Omega-3-acid ethyl esters
Omnaris (cirlesonide)
OmniscanThis drug has as active FDA Safety Alert (gadodiamide)
OptiMARK (gadoversetamide)
Optison (perflutren protein-type A microspheres)
Orencia (abatacept)
Orfadin (nitisinone)
Orlistat
Ortho Evra (norelgestromin; ethinyl estradiol)
Oseltamivir phosphate
OsmoprepThis drug has as active FDA Safety Alert (sodium phosphate)
Oxaliplatin
OxcarbazepineThis drug has as active FDA Safety Alert


back to top

P
PaceroneThis drug has as active FDA Safety Alert (amiodarone)
Palifermin
Paliperidone
PamidronateThis drug has as active FDA Safety Alert
Panitumumab
Panretin Gel (alitretinoin)
Pantoprazole
Paricalcitol
ParoxetineThis drug has as active FDA Safety Alert
PaxilThis drug has as active FDA Safety Alert (paroxetine)
Pegaptanib
Pegvisomant
Pemetrexed
PemolineThis drug has as active FDA Safety Alert
Pentobarbital and carbromal
Perflutren lipid microspheres
PerindoprilThis drug has as active FDA Safety Alert
PhenerganThis drug has as active FDA Safety Alert (promethazine)
Pimecrolimus
PioglitazoneThis drug has as active FDA Safety Alert
Placidyl (ethchlorvynol)
Plan B (levonorgestrel)
Pletal (cilostazol